On the heels of his study, Dr. James Berenson an oncologist specializing in multiple myeloma —announced his latest findings and with his cancer patients, shared their challenging experiences during this pandemic.
Go to article Click Here
Cancer Patients Join Oncologist Who Releases Results of COVID-19 Vaccine/Cancer Study
About Michael cacciotti
View all posts by Michael cacciottiSubscribe
Subscribe to our e-mail newsletter to receive updates.
James R. Berenson, MD
- President & CEO, Institute for Myeloma & Bone Cancer Research (IMBCR)
- President & Medical Director. Berenson Cancer Center (Berensoncancercenter)
- Founder & President, ONCOtherapeutics
- Founder & Principal, ONCOtracker
-
Cancer Patients Join Oncologist Who Releases Results of COVID-19 Vaccine/Cancer Study
-
IMBCR & Emory University’s Big Discovery!!!
-
James R. Berenson, MD, Inc. Announces Rebranding and Changes Organization Name to Berenson Cancer Center
- What Is Multiple Myeloma?
-
Video Updates
- Kyphon® Balloon Kyphoplasty Found Beneficial for Treating Spinal Fractures in Cancer Patients
- The histone deacetylase inhibitor LBH589 enhances the anti-myeloma effects of chemotherapy in vitro and in vivo
- Oncology CRO Oncotherapeutics Presents at ASH 2011 Annual Meeting
- Understanding Myeloma News About Secondary Cancers and Clotting
-
Dedication of “Determination”
February 8, 2022
Press Releases